Penwest Announces That Endo Reports Receiving Final FDA Approval For Oxymorphone ER

Sat, 24 Jun 2006 11:00 AM EST

... PenwestPharmaceuticals Co. (Nasdaq: PPCO) today announced that EndoPharmaceuticals Inc., Penwest's partner in the development andcommercialization of oxymorphone extended release tablets (oxymorphone ER),reported that the U.S. [click link for full article] ...